GlassScriptPhysician profile
Kathleen S Johnson
NPI 1104819689
$2,086.02
in general payments reported to CMS, 2019-2025
28 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $140 · 2021: $266 · 2022: $429 · 2023: $239 · 2024: $353 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866 · Consulting Fee: $30.00 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.02 |
| Consulting Fee | $30.00 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $390.24 | 2022-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $245.48 | 2019-2024 | Acessa Provu System |
| Abbvie INC. | $227.00 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $138.07 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $136.36 | 2019-2021 | |
| Aspira Women'S Health INC | $124.70 | 2022 | |
| Coopersurgical, INC. | $86.23 | 2021-2023 | Wallach Cryosurgical Equipment, Mara Console |
| Shield Therapeutics INC | $81.36 | 2023-2024 | Accrufer |
| Myovant Sciences INC. | $79.50 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $60.77 | 2022-2025 | |
| Channel Medsystems, INC. | $55.91 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.55 | 2025 | |
| Scynexis, INC. | $45.14 | 2022 | |
| Pfizer INC. | $40.58 | 2023-2024 | |
| Lupin INC. | $39.48 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $37.59 | 2019 | |
| Agile Therapeutics, INC. | $33.22 | 2021 | |
| Smith+Nephew, INC. | $27.72 | 2025 | Pico 14 |
| Acessa Health INC. | $24.05 | 2020 | |
| Radius Health, INC. | $23.38 | 2022 | |
| Amgen INC. | $20.14 | 2020 | |
| Therapeuticsmd, INC. | $19.38 | 2019 | |
| Baxter Healthcare | $18.03 | 2024 | Perclot |
| Amag Pharmaceuticals, INC. | $17.95 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.41 | 2019 | |
| Ethicon US, LLC | $16.45 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.98 | 2022 | |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.